1. Targeting mitochondrial dysfunction in atopic dermatitis with trilinolein: A triacylglycerol from the medicinal plant Cannabis fructus.
- Author
-
Wang, Yi, Lu, Hanzhi, Cheng, Linyan, Guo, Wanjun, Hu, Yue, Du, Xinran, Liu, Xin, Xu, Mingyuan, Liu, Yeqiang, Zhang, Yanbin, Xi, Ruofan, Wang, Peiyao, Duan, Yanjuan, Zhu, Jianyong, and Li, Fulun
- Abstract
• The 12 main compounds of Cannabis fructus were identified using HPLC-ESI-MS/MS. Trilinolein was extracted and shown to have anti-inflammatory and antioxidant effects both in vitro and in vivo. • Trilinolein prevents dinitrochlorobenzene (DNCB)-induced atopic dermatitis (AD)-like lesions and restores the skin barrier in BALB/c mice. • Trilinolein attenuates IL-4- and TNF-α-induced mitochondrial DNA (mtDNA) release and ROS production in HaCaT cells via the AhR-Nrf2 pathway. Atopic dermatitis (AD) is a common skin condition that causes chronic and recurring eczema lesions. Prior research has indicated that Cannabis fructus , the mature fruit of Cannabis sativa, has an antioxidant effect. Historically, Cannabis fructus has been used in cosmetics and medicine. However, there is limited knowledge regarding its biological components and the mechanisms by which it prevents and treats AD. HPLC-ESI-MS/MS analysis was utilized to identify the main compounds of Cannabis fructus , and trilinolein was extracted using chromatographic techniques. The potential of trilinolein in the prevention of AD was assessed, and its underlying mechanisms of action were elucidated. The distribution of distinct cellular subpopulations and the principal biological processes implicated in the pathogenesis of AD were assessed through a comparative study involving chronic AD patients and healthy controls (HCs). Differential gene expression was validated in clinical samples from the lesions of AD patients and the healthy skin of controls. The pharmacodynamic activity of trilinolein was validated in dinitrochlorobenzene (DNCB)-induced BALB/c mice and in IL-4- and TNF-α-induced HaCaT cells. Proteomics analyse was employed to investigate its mechanisms. Single-cell transcriptome analysis revealed that chronic AD is characterized by abnormal keratinocyte differentiation and oxidative stress damage. When topically applied, trilinolein can effectively improve AD-like skin lesions induced by DNCB. It increases the expression of terminal differentiation proteins and decreases the expression of NADPH oxidase 2 (NOX2), with a therapeutic effect comparable to that of the positive control drug crisaborole. Additionally, trilinolein reduced ROS fluorescence intensity, restored mitochondrial morphology and membrane potential, and decreased mitochondrial DNA (mtDNA) release in keratinocytes stimulated with IL-4 and TNF-α. Moreover, trilinolein increased the protein expression of AhR, CYP1A1, and Nrf2 in a dose-dependent manner. The effect of trilinolein on keratinocyte terminal differentiation proteins and ROS levels was blocked by the addition of an AhR inhibitor. The study suggests that trilinolein from Cannabis fructus alleviates NOX2-dependent mitochondrial dysfunction and repair the skin barrier via AhR-Nrf2 pathway, making it a promising agent for the prevention and treatment of AD. [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF